DNA
Ginkgo Bioworks Holdings Inc. Class A
$12.58
+$0.55(+4.59%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$629.29M
Volume
1.43M
52W Range
$5.00 - $16.85
Target Price
$10.25
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $313.8M | $477.7M | $251.5M | $227.0M | ||
| Total Revenue | $313.8M | $477.7M | $251.5M | $227.0M | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | $109.7M | $204.2M | $54.0M | -- | ||
| GROSS PROFIT | ||||||
| Gross Profit | $204.2M | $273.5M | $251.5M | $182.5M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $2.1B | $2.5B | $1.1B | $786.8M | ||
| Research & Development | $1.1B | $1.1B | $580.6M | $424.1M | ||
| Research Expense | $1.1B | $1.1B | $580.6M | $424.1M | ||
| Selling, General & Administrative | $863.0M | $1.4B | $385.0M | $246.2M | ||
| General & Administrative Expenses | $863.0M | $1.4B | $385.0M | $246.2M | ||
| Salaries & Wages | $1.6B | -- | -- | -- | ||
| Depreciation & Amortization | $29.1M | $42.6M | $70.5M | $63.0M | ||
| Depreciation & Amortization | $29.1M | -- | -- | -- | ||
| Amortization | $21.3M | $62.1M | $50.3M | $655.0K | ||
| Other Operating Expenses | $1.7M | $-7.6M | $-9.1M | $-3.9M | ||
| OPERATING INCOME | ||||||
| Operating income | $-1.8B | $-2.2B | $-864.4M | $-559.8M | ||
| EBITDA | $-1.8B | $-2.1B | $-794.0M | $-456.3M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $2.4M | $106.0K | $93.0K | $94.0K | ||
| Intinc | $837.0K | $20.3M | $57.2M | $38.6M | ||
| Net Non-Operating Interest Income/Expense | $-1.5M | $20.2M | $57.1M | $38.5M | ||
| Gain on Sale of Securities | $-11.5M | $-53.3M | $-54.8M | $-28.8M | ||
| Other Income/Expense | $6.4M | $67.4M | $191.0M | $30.1M | ||
| Other Special Charges | $82.4M | $125.0M | $5.2M | $5.7M | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | $2.2B | -- | -- | $24.2M | ||
| Special Income Charges | $-2.2B | $-11.4M | $-3.2M | $-72.0M | ||
| Impairment of Capital Assets | -- | -- | -- | $47.9M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-1.8B | $-2.1B | $-892.8M | $-547.4M | ||
| Pre-Tax Income | $-1.8B | $-2.1B | $-892.9M | $-547.5M | ||
| INCOME TAX | ||||||
| Tax Provision | $-1.5M | $-15.0M | $-71.0K | $-479.0K | ||
| NET INCOME | ||||||
| Net Income | $-1.8B | $-2.1B | $-892.9M | $-547.0M | ||
| Net Income (Continuing Operations) | $-1.8B | $-2.1B | $-892.9M | $-547.0M | ||
| Net Income (Discontinued Operations) | $-1.8B | $-2.1B | $-892.9M | $-547.0M | ||
| Net Income (Common Stockholders) | $-1.8B | $-2.1B | $-892.9M | $-547.0M | ||
| TOTALS | ||||||
| Total Expenses | $2.3B | $2.7B | $1.1B | $786.8M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $34.0M | $42.0M | $48.6M | $51.9M | ||
| Average Shares Outstanding (Diluted) | $34.0M | $42.0M | $48.6M | $51.9M | ||
| Shares Outstanding | $36.8M | $48.8M | $53.8M | $58.0M | ||
| Basic EPS | $-54 | $-50 | $-18.4 | $-10.54 | ||
| Basic EPS (Continuing Operations) | $-54 | $-50 | $-18.4 | $-10.54 | ||
| Diluted EPS | $-55.6 | $-50 | $-18.4 | $-10.54 | ||
| Diluted EPS (Continuing Operations) | $-55.6 | $-50 | $-18.4 | $-10.54 | ||
| OTHER METRICS | ||||||
| Earnings from equity interest | $-77.3M | $-43.8M | $-2.6M | -- | ||
| Earnings From Equity Interest Net Of Tax | $-77.3M | $-43.8M | $-2.6M | -- | ||
| Gain On Sale Of Business | -- | $31.9M | $-42.5M | $-7.0M | ||
| Minority Interests | $6.6M | $1.4M | -- | -- | ||
| Other Gand A | $863.0M | $1.4B | $385.0M | $246.2M | ||
| Other Impairment Of Capital Assets | -- | -- | $96.2M | $20.8M | ||
| Rent And Landing Fees | $17.7M | -- | -- | -- | ||
| Restruct | $2.2B | -- | -- | $24.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNA | $12.58 | +4.6% | 1.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW